EUVIMEDEUVIMED entdecken
Crossref

Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population

Marion Camoin iD, Kamel Mohammedi iD, Pierre-Jean Saulnier iD, Samy Hadjadj iD, Jean-François Gautier iD, Jean-Pierre Riveline iD, Nicolas Venteclef iD, Louis Potier iD, Gilberto Velho iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Marion Camoin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetology and Endocrinology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris 75018, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetic Nephropathies, Renal Insufficiency, Chronic, Body Weight. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Intraindividual body-weight variability or cycling is associated with increased risk of chronic kidney disease (CKD) in the general population.

Objective

We conducted a retrospective analysis of data from the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) studies to assess association between body-weight cycling and the risk of renal events in type 1 diabetes.

Methods

Four indices of intraindividual body-weight variability were calculated for 1432 participants of DCCT/EDIC taking into account body-weight measurements during the DCCT follow-up (6 ± 2 years). Variability independent of the mean (VIM) was the main index. Six criteria of progression to CKD were studied during DCCT/EDIC follow-up (21 ± 4 years). Hazard ratio (HR) with 95% confidence interval (CI) were computed in Cox analyses for 1 SD of the indices expressed as Z-score.

Results

A high VIM was significantly associated with the incidence of a 40% decline in eGFR from baseline values (HR, 1.25; 95% CI, 1.09-1.41; P = .001), doubling of baseline serum creatinine (HR, 1.34; 95% CI, 1.13-1.57; P = .001), CKD stage 3 (HR, 1.36; 95% CI, 1.12-1.63; P = .002), and with a decline in eGFR > 3 mL/min/m2 per year (all analyses adjusted for CKD risk factors at baseline and follow-up, and use of nephroprotective drugs). VIM was also associated with the incidence of moderately and severely increased albuminuria, but associations did not remain significant following adjustment for follow-up covariates. Similar results were observed for the other indices of body-weight cycling.

Conclusion

Body-weight cycling is significantly associated with an increased risk of kidney events in people with type 1 diabetes, regardless of body mass index and traditional risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetic NephropathiesRenal Insufficiency, ChronicBody WeightHumansMaleFemaleRetrospective StudiesDisease ProgressionRisk FactorsFollow-Up StudiesAdultChildGlomerular Filtration RateYoung AdultAdolescentIncidence

Stichwörter der Autor:innen

albuminuriabody weight-cyclingchronic kidney diseasemicrovasculartype 1 diabetes

Autor:innen und Institutionen

  • Department of Diabetology and Endocrinology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris 75018, France.
  • Department of Endocrinology, Diabetes and Nutrition, Bordeaux University Hospital (Hôpital Haut-Lévêque), Pessac 33600, France.
  • Inserm U1034, Biologie des Maladies Cardiovasculaires, Pessac 33600, France.
  • INSERM, CHU Poitiers, Clinical Investigation Center CIC 1402, University of Poitiers, Poitiers 86000, France.
  • Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, Nantes 44000, France.
  • INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Université Paris Cité, Paris 75730, France.

ORCID-Profile: Marion Camoin, Kamel Mohammedi, Pierre-Jean Saulnier, Samy Hadjadj, Jean-François Gautier, Jean-Pierre Riveline, Nicolas Venteclef, Louis Potier, Gilberto Velho

Zitieren

APA

Camoin, M., Mohammedi, K., Saulnier, P. J., Hadjadj, S., Gautier, J. F., Riveline, J. P., Venteclef, N., Potier, L., & Velho, G. (2025). Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae852

Vancouver

Camoin M, Mohammedi K, Saulnier PJ, Hadjadj S, Gautier JF, Riveline JP, et al. Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae852

BibTeX
@article{Camoin2025,
  author = {Camoin, Marion and Mohammedi, Kamel and Saulnier, Pierre-Jean and Hadjadj, Samy and Gautier, Jean-François and Riveline, Jean-Pierre and Venteclef, Nicolas and Potier, Louis and Velho, Gilberto},
  title = {Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae852}
}
Kostenlos starten →